SEQUENT MEDICAL, INC.
Woven EndoBridge (WEB) device—a minimally-invasive intracranial aneurysm treatment implant that occludes broad-necked aneurysms without requiring support devices or antiplatelet therapy
- Sector
- Medtech
- Headquarters
- ALISO VIEJO, CA
- Founded
- 2006
- Latest Form D
- $20M, Apr 2014
- Total capital
- $66.2M
- Federal grants
- $1.1M
- 1 award · 2016
- Rank in peer group#441 of 477
- Private capital raised
- $65.2M
- 5 Form D · last Apr 2014
- 151 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 31
- 9 pending · first 2013
- Rank in peer group#4 of 477
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of Intrasaccular Flow Disrupters for Small and Ruptured Aneurysms$1.1M
- Private capital raisedForm D · SEC · 5th filing$20M
- Private capital raisedForm D · SEC · 4th filing$26M
- Private capital raisedForm D · SEC · 3rd filing$15.6M
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$2.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#4 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Brian J. CoxResearcherDirectorLinked by 1 patent
- Donald B. MilderDirectorNamed in SEC Form D filings
- James J. BochnowskiDirectorNamed in SEC Form D filings
- Jonathan B. RootDirectorNamed in SEC Form D filings
- Kevin J. CousinsExecutive OfficerNamed in SEC Form D filings
- Kirk G NielsenDirectorNamed in SEC Form D filings
Show all 10 people
- Nimesh F. ShahDirectorNamed in SEC Form D filings
- Robert F. RosenbluthExecutive Officer, DirectorNamed in SEC Form D filings
- Thomas C. WilderExecutive Officer, DirectorNamed in SEC Form D filings
- Thomas C. Wilder, IIIExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 31 granted of 40- GrantedFilamentary Devices For Treatment Of Vascular DefectsUSPTOUS 11,559,309
- PendingFilamentary Devices For Treatment Of Vascular DefectsUSPTOApplication 17572988
- GrantedBraiding Mechanism And Methods Of UseUSPTOUS 11,352,724
Show all 40 patent records
- Filamentary Devices For Treatment Of Vascular DefectsJan 24, 2023 · US 11,559,309Granted
- Filamentary Devices For Treatment Of Vascular DefectsAug 11, 2022 · Application 17572988Pending
- Braiding Mechanism And Methods Of UseJun 7, 2022 · US 11,352,724Granted
- Filamentary Devices For Treatment Of Vascular DefectsMay 3, 2022 · US 11,317,921Granted
- Filamentary Devices Having A Flexible Joint For Treatment Of Vascular DefectsApr 5, 2022 · US 11,291,453Granted
- Methods And Devices For Treatment Of Vascular DefectsNov 23, 2021 · US 11,179,159Granted
- Systems And Methods For Delivery Of Stents And Stent-like DevicesMar 23, 2021 · US 10,952,739Granted
- Filamentary Devices For The Treatment Of Vascular DefectsMar 9, 2021 · US 10,939,914Granted
- Delivery And Detachment Systems And Methods For Vascular ImplantsMar 2, 2021 · US 10,932,787Granted
- Braiding Mechanism And Methods Of UseFeb 2, 2021 · US 10,907,283Granted
- Filamentary Devices For Treatment Of Vascular DefectsJan 14, 2021 · Application 16815911Pending
- Systems And Methods For Embolization Of Body StructuresJan 5, 2021 · US 10,881,413Granted
- Filamentary Devices For Treatment Of Vascular DefectsOct 27, 2020 · US 10,813,645Granted
- Filamentary Devices For Treatment Of Vascular DefectsApr 7, 2020 · US 10,610,231Granted
- Braiding Mechanism And Methods Of UseApr 16, 2019 · US 10,260,183Granted
- Braiding Mechanism And Methods Of UseApr 16, 2019 · US 10,260,182Granted
- Multiple Layer Filamentary Devices For Treatment Of Vascular DefectsMar 26, 2019 · US 10,238,393Granted
- Filamentary Devices For Treatment Of Vascular DefectsNov 27, 2018 · US 10,136,896Granted
- Delivery And Detachment Systems And Methods For Vascular ImplantsNov 13, 2018 · US 10,123,802Granted
- Filamentary Devices For Treatment Of Vascular DefectsMay 1, 2018 · US 9,955,976Granted
- Devices For Therapeutic Vascular ProceduresMay 11, 2017 · Application 15404492Pending
- Devices For Therapeutic Vascular ProceduresApr 25, 2017 · US 9,629,635Granted
- Braiding Mechanism And Methods Of UseApr 25, 2017 · US 9,631,303Granted
- Braiding Mechanism And Methods Of UseDec 27, 2016 · US 9,528,205Granted
- Filamentary Devices For Treatment Of Vascular DefectsNov 15, 2016 · US 9,492,174Granted
- Filamentary Devices For Treatment Of Vascular DefectsMar 29, 2016 · US 9,295,473Granted
- Blood Flow Disruption Devices And Methods For The Treatment Of Vascular DefectsFeb 18, 2016 · Application 14926423Pending
- Methods And Devices For Treatment Of Vascular DefectsFeb 16, 2016 · US 9,259,337Granted
- Delivery And Detachment Systems And Methods For Vascular ImplantsJan 26, 2016 · US 9,241,718Granted
- Methods And Devices For Treatment Of Vascular DefectsJan 21, 2016 · Application 14869688Pending
- Filamentary Devices For Treatment Of Vascular DefectsDec 1, 2015 · US 9,198,670Granted
- Filamentary Devices For Treatment Of Vascular DefectsJul 14, 2015 · US 9,078,658Granted
- Filamentary Devices For Treatment Of Vascular DefectsJun 4, 2015 · Application 14577923Pending
- Filamentary Devices For Treatment Of Vascular DefectsApr 16, 2015 · Application 14577802Pending
- Embolic Occlusion Device And MethodNov 6, 2014 · Application 14271099Pending
- Delivery And Detachment Systems And Methods For Vascular ImplantsNov 4, 2014 · US 8,876,855Granted
- Braiding Mechanism And Methods Of UseSep 16, 2014 · US 8,833,224Granted
- Braiding Mechanism And Methods Of UseSep 2, 2014 · US 8,820,207Granted
- Methods And Devices For Treatment Of Vascular DefectsFeb 20, 2014 · Application 14044349Pending
- Delivery And Detachment Systems And Methods For Vascular ImplantsDec 3, 2013 · US 8,597,323Granted
Related companies, and why
- CERVU, INCSimilar federal contract value in Medtech · null in contracts
- CLINICAL SENSORS, INC.Similar federal contract value in Medtech · null in contracts
- NEUROGAMI MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
- GP IONICS LLCSimilar federal contract value in Medtech · null in contracts
- PRELUDE CORPORATIONSimilar federal contract value in Medtech · null in contracts
- EIT USA, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .